Prostacyclin increases cyclic-nucleotide responsiveness of lymphocytes from patients with systemic sclerosis.
Low cyclic-AMP levels within lymphocytes from five patients with systemic sclerosis showed a striking increase in response to isoprenaline after intravenous infusion of prostacyclin.